TP53 and neoplasm: However, the overabundance of mutant p53 protein in tumors is usually directly linked to secondary genetic alterations such as aneuploidy and loss of p16INK4A or Mdm2 [56–59], in addition to TP53 loss of function, and may therefore contribute to tumor progression only at later stages [41].